ISTA PHARMACEUTICALS INC Research and Development Expense
ISTA PHARMACEUTICALS INC reported Research and Development Expense of $9.49 million for the 3-month period ending 2012-03-31, per its 10-Q filed 2012-05-04.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2012-05-04
- ISTA PHARMACEUTICALS INC research and development expense for the quarter ending 2012-03-31 was $9.49M, a 8.25% decline year-over-year.
- ISTA PHARMACEUTICALS INC research and development expense for the quarter ending 2011-12-31 was $4.71M, a 42.16% decline year-over-year.
- ISTA PHARMACEUTICALS INC research and development expense for the quarter ending 2011-09-30 was $7.72M, a 2.83% decline year-over-year.
- ISTA PHARMACEUTICALS INC research and development expense for the quarter ending 2011-06-30 was $8.85M, a 75.91% increase year-over-year.
- ISTA PHARMACEUTICALS INC research and development expense for fiscal 2011 was $31.63M, a 21.98% increase from fiscal 2010.
- ISTA PHARMACEUTICALS INC research and development expense for fiscal 2010 was $25.93M, a 4.12% increase from fiscal 2009.
- ISTA PHARMACEUTICALS INC research and development expense for fiscal 2009 was $24.90M.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2012-03-31 | $9.49M 10-Q · filed 2012-05-04 | $14.21M derived: sum of 2 quarters · filed 2012-05-04 | $21.93M derived: sum of 3 quarters · filed 2012-05-04 | $30.77M derived: sum of 4 quarters · filed 2012-05-04 |
| 2011-12-31 | $4.71M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | $12.43M derived: sum of 2 quarters · filed 2012-02-27 | $21.28M derived: sum of 3 quarters · filed 2012-02-27 | $31.63M 10-K · filed 2012-02-27 |
| 2011-09-30 | $7.72M 10-Q · filed 2011-11-07 | $16.57M derived: sum of 2 quarters · filed 2011-11-07 | $26.91M 10-Q · filed 2011-11-07 | $35.06M derived: sum of 4 quarters · filed 2012-05-04 |
| 2011-06-30 | $8.85M 10-Q · filed 2011-08-01 | $19.19M 10-Q · filed 2011-08-01 | $27.34M derived: sum of 3 quarters · filed 2012-05-04 | $35.29M derived: sum of 4 quarters · filed 2012-05-04 |
| 2011-03-31 | $10.34M 10-Q · filed 2012-05-04 | $18.49M derived: sum of 2 quarters · filed 2012-05-04 | $26.44M derived: sum of 3 quarters · filed 2012-05-04 | $31.47M derived: sum of 4 quarters · filed 2012-05-04 |
| 2010-12-31 | $8.15M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | $16.09M derived: sum of 2 quarters · filed 2012-02-27 | $21.13M derived: sum of 3 quarters · filed 2012-02-27 | $25.93M 10-K · filed 2012-02-27 |
| 2010-09-30 | $7.95M 10-Q · filed 2011-11-07 | $12.98M derived: sum of 2 quarters · filed 2011-11-07 | $17.78M 10-Q · filed 2011-11-07 | |
| 2010-06-30 | $5.03M 10-Q · filed 2011-08-01 | $9.83M 10-Q · filed 2011-08-01 | ||
| 2009-12-31 | $24.90M 10-K · filed 2012-02-27 |